JBS3 Report

Full Version available at Heart

Recommendations from each section

General Recommendations

  • Use JBS3 risk calculator to estimate both 10-year risk and lifetime risk of CVD in all individuals except for those with existing CVD or certain high risk diseases i.e. diabetes age >40 years, patients with chronic kidney disease (CKD) stages 3-5, or familial hypercholesterolaemia (FH).
  • Total cholesterol and HDL-cholesterol from a non-fasting blood sample should be used for lipid profile estimate of CVD risk in the JBS3 calculator
  • Non-HDL-cholesterol, measured from a non-fasting blood sample as total cholesterol minus HDL-cholesterol, should be used in preference to LDL-cholesterol as the treatment goal for lipid-lowering therapy.
  • Intensive risk factor modification with diet, lifestyle intervention and pharmacological therapy in patients with existing CVD, without the need for estimation of CVD risk.
  • Intensive risk factor modification with diet, lifestyle intervention and pharmacological therapy, in individuals at particularly high risk of developing CVD: i.e. diabetics age >40 years, patients with CKD stages 3–5, or FH without the need for estimation of CVD risk.
  • Diet, lifestyle intervention and pharmacological therapy in people at high short-term risk. Thresholds for treatment with statins based on 10-year CVD risk will be informed by NICE guidelines.
  • Diet, lifestyle intervention and for some people, pharmacological therapy, in those with increased modifiable lifetime risk as informed by JBS3 calculator metrics.

1. Risk Model Refinement Recommendations

2. Lifestyle Recommendations

3. Childhood and Adult Obesity Recommendations

4. Lipid Recommendations

5. Blood Pressure Recommendations

6. Established CVD Recommendations

7. Post Myocardial Infarction Recommendations

8. Stroke Recommendations

9. Peripheral Arterial Disease Recommendations

10. Diabetes Mellitus Recommendations

11. Chronic Kidney Disease Recommendations

12. Chronic Inflammatory Disease Recommendations

13. Chronic Obstructive Sleep Apnoea/Hypopnoea Recommendations

14. Implementation Recommendations